This activity is intended for internal CCAD Physicians

Activity Description:

This activity is based on on the American College of Surgeons, Commission on Cancer standards. To meet the Commission on Cancer (CoC) standards for multidisciplinary cancer case conferences aka tumor boards cancer programs hold multidisciplinary cancer case conference(s) to evaluate patient management.

Target Audience: 

Endocrinology, Gastroenterology, Hematology/Oncology, Nursing, Pathology, Pharmacology, Pulmonology, Radiology and Surgery.

Learning Objectives:

Participants will be able to achieve the below:

• Demonstrate proficiency in staying updated on the latest advancements in HPB research, treatment modalities, and evidence-based guidelines including but not limited to pancreatic, biliary and liver cancer. This will be evident through the use of evidence-based practice guidelines and care pathways for HPB cancers during tumor board meetings to develop personalized treatment plans for patients.
• Exhibit effective communication and collaboration skills within the HPB tumor board setting to foster efficient and coordinated patient care. This includes articulating viewpoints clearly, actively listening to others, and engaging in respectful dialogue.
• Incorporate a patient-centered approach into the HPB board discussions. Board professionals will excel in ensuring that patient preferences and values are considered when formulating treatment plans. Recognizing the importance of shared decision-making in the treatment planning process, this approach will enhance patient satisfaction and engagement.
• Remain informed about emerging strategies and technologies in HPB cancer care. By continually evaluating and incorporating these advancements, board professionals can optimize performance in providing the highest quality and most effective care to cancer patients.

Faculty Disclosure:

In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Abu Dhabi for Continuing Education mitigates all faculty conflicts of interest to ensure CME activities are free of commercial bias.

Activity Director(s): Essa Aleassa, MD, Yasir Akmal, MD

The planning committee, faculty, and others in control of content (either individually or as a group) have NO relevant financial relationship(s) to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation Statement:

Cleveland Clinic Abu Dhabi for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for to provide continuing education for the healthcare team.

Credit Designation:

This activity was designated for 1.00 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.